Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| SRPT | SAREPTA THERAPEUTICS INC | United States | $12.27B | 94,523,766 | 73.96% | 26.04% | Net Buying | Net Selling |
| FENC | FENNEC PHARMACEUTICALS INC | United States | $185.24M | 27,322,141 | 4.04% | 95.96% | Net Buying | Net Selling |
| TGTX | TG THERAPEUTICS INC | United States | $2.52B | 154,542,945 | 53.50% | 46.50% | Net Selling | Net Selling |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | United States | $1.67B | 56,791,861 | 61.46% | 38.54% | Net Selling | Net Selling |
| HALO | HALOZYME THERAPEUTICS INC | United States | $5.64B | 127,274,000 | 77.98% | 22.02% | Net Selling | Net Buying |
| INCY | INCYTE CORP | United States | $12.98B | 224,540,751 | 79.12% | 20.88% | Net Selling | Net Buying |
| MNKD | MANNKIND CORP | United States | $1.27B | 272,315,846 | 30.11% | 69.89% | Net Selling | Net Selling |
| CORT | CORCEPT THERAPEUTICS INC | United States | $3.14B | 104,112,088 | 32.60% | 67.40% | Net Buying | Net Buying |
| CPRX | CATALYST PHARMACEUTICALS INC | United States | $1.91B | 118,115,079 | 81.35% | 16.30% | Net Buying | Net Selling |
| RPRX | ROYALTY PHARMA PLC | United States | $16.38B | 597,437,271 | 51.39% | 16.57% | Net Selling | Net Buying |
| GMAB | GENMAB A | Denmark | $18.65B | 66,122,964 | 72.37% | 0.00% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | United States | $14.25B | 189,879,803 | 96.22% | 1.65% | Net Selling | Net Selling |
| PBYI | PUMA BIOTECHNOLOGY INC | United States | $185.72M | 48,238,850 | 58.01% | 41.99% | Net Selling | |
| TECH | BIO-TECHNE CORP | United States | $12.16B | 157,584,637 | 97.68% | 2.32% | Net Buying | Net Selling |
| EXEL | EXELIXIS INC | United States | $6.32B | 291,292,704 | 85.75% | 4.31% | Net Buying | Net Buying |
| JAZZ | JAZZ PHARMACEUTICALS PLC | Ireland | $6.63B | 63,039,618 | 27.88% | 72.12% | Net Selling | Net Selling |
| BNTX | BIONTECH SE | Germany | $23.92B | 237,725,735 | 17.22% | 0.00% | ||
| MDXG | MIMEDX GROUP INC | United States | $1.06B | 147,603,955 | 43.84% | 56.16% | Net Buying | Net Selling |
| REGN | REGENERON PHARMACEUTICALS INC | United States | $108.00B | 110,185,503 | 69.51% | 30.49% | Net Selling | Net Selling |
| UTHR | UNITED THERAPEUTICS CORP | United States | $12.20B | 44,355,694 | 87.63% | 12.37% | Net Selling | Net Selling |
| NVO | NOVO NORDISK A S | Denmark | $610.11B | 4,510,000,000 | 7.18% | 0.00% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.